The Motley Fool

Biden’s Win Is Huge for These 2 Cannabis Stocks

Image source: Getty Images

U.S.President-Elect Joe Biden is ready to be sworn in on January 20. Investors might be asking the question: which stocks will benefit from this change in leadership?

I have two cannabis picks for investors asking these important questions.

Legalization could actually happen south of the border

The Democratic Party consists of a large number of individuals spanning the left-wing spectrum. Some Democrat leaders have publicly supported the idea of legalizing marijuana. More moderate leaders do not support of the idea. Joe Biden was elected as a democratic candidate with a more moderate view, so many speculate legalizing marijuana is low on his priority list right now (if it’s even on there). Given the problems the country has with the coronavirus pandemic, I wouldn’t expect any news soon.

That said, should we enter some level of normalcy sometime soon, cannabis legalization could come up for discussion. The Canadian cannabis sector is one which is being driven by growth prospects in the U.S. Accordingly, any positive news on legalization would likely cause hysteria much like we saw in 2018.

For those willing to speculate, my top two picks for investors to consider right now are Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) and Aphria Inc. (TSX:APHA)(NYSE:APHA).


Canopy holds the mantle of being the most investible cannabis stock out there, for a number of reasons. The company has not engaged in a big way in the hype-related M&A activity in 2018 and 2019 when stock prices were sky-high. Rather, this company has focused on lowering costs and increasing market share in its core businesses as well as growth sectors.

A large investment from Constellation Brands, one of the largest U.S. alcoholic beverage behemoths, has positioned Canopy well for growth in the cannabis-infused beverage business. Constellation’s U.S. operations are also a leg up in terms of distribution and cross-border issues other Canadian competitors have.

This company’s stock price has been less volatile than its peers. I think this is due to the more mature nature of this company relative to the more “junior” smaller-cap plays on the TSX.


Aphria has recently agreed to merge with Tilray Inc, whose U.S. exposure is something that investors have cheered perhaps more than anything in this merger. The company recently announced an acquisition of a brewer out of Atlanta with distribution in 27 states for US$300 million. Competition in the cananbis-infused beverage and cannabis 2.0 products segment is heating up. Accordingly, Aphria’s hopes to compete have increased substantially as a result of this merger.

The combined entity will have the firepower to compete with Canopy and grow market share in the U.S. potentially at a faster rate than Canopy presently. Potential risks around the deal falling through do exist, so trade carefully.

Bottom line

The likelihood of such a scenario ought to be considered. Cannabis legalization in the U.S. remains a long-shot. That said, investors seem to be pricing some likelihood into cannabis prices. The entire sector has seen a sharp spike post-election, largely pricing in these hopes. Investors looking for the next hot sector to bet on ought to consider these two plays on U.S. legalization.

Here are other great stocks that could skyrocket:

The 10 Best Stocks to Buy This Month

Renowned Canadian investor Iain Butler just named 10 stocks for Canadians to buy TODAY. So if you’re tired of reading about other people getting rich in the stock market, this might be a good day for you.

Because Motley Fool Canada is offering a full 65% off the list price of their top stock-picking service, plus a complete membership fee back guarantee on what you pay for the service. Simply click here to discover how you can take advantage of this.

Click Here to Learn More Today!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss an important event.

Iain Butler and the Stock Advisor Canada team only publish their new “buy alerts” twice a month, and only to an exclusively small group.

This is your chance to get in early on what could prove to be very special investment advice.

Enter your email address below to get started now, and join the other thousands of Canadians who have already signed up for their chance to get the market-beating advice from Stock Advisor Canada.